MedTrace Logo

Adding Ketamine to Low Dose Bupivacaine in Saddle Block for Perianal Surgery

NCT03264430 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-01-17

No results posted yet for this study

Summary

Evaluation of the anesthetic quality and analgesic efficacy of adding ketamine to intrathecal bupivavaine in selective saddle block for perianal surgery.

Conditions

Interventions

DRUG

Ketamine

an antagonist of the NMDA receptor

DRUG

bupivacaine

local anaesthetic

Sponsors & Collaborators

  • Esam Eldin Mohamed Abdalla

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-10-31
Completion
2018-12-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03264430 on ClinicalTrials.gov